At the news
? BULLISHIMPACT 7/10 PRESS-RELEASE filed Apr 13, 2026 at 08:00 ET
Stryker announced a definitive agreement to acquire Amplitude Vascular Systems, a private developer of next-generation intravascular lithotripsy (IVL) technology for treating calcified peripheral arterial disease. The acquisition strengthens Stryker’s Peripheral Vascular portfolio and advances its strategy in arterial disease treatment, with the deal subject to customary closing conditions.
- Stryker is acquiring Amplitude Vascular Systems (AVS), a privately held company developing a next-generation IVL platform for calcified peripheral arterial disease.
- AVS’ technology uses pulsed CO₂-generated pressure waves via a balloon catheter to fracture calcium and improve luminal gain, enhancing deliverability and treatment efficiency.
- The acquisition expands Stryker’s Peripheral Vascular (PV) portfolio and supports its strategy to build a comprehensive PV platform.
- Transaction is subject to customary closing conditions; both companies will operate independently until closing.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access